Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.8M Sell
1,220,602
-952,544
-44% -$20.7M 1.29% 28
2026
Q1
$37.7M Buy
2,173,146
+587,926
+37% +$11.1M 1.26% 31
2025
Q4
$29.9M Sell
1,585,220
-597,561
-27% -$10M 0.96% 41
2025
Q3
$31.7M Buy
+2,182,781
New +$31.1M 0.94% 34

Other funds holding CDNA

Braidwell's CDNA Position: Q2 2026 in Review

Braidwell reduced its CareDx (CDNA) stake by 44% in Q2 2026, selling an estimated $20.7M and leaving 1,220,602 shares worth $34.8M. The position accounts for 1.29% of the portfolio, ranked #28.

Braidwell first reported a position in CDNA in Q3 2025 and has held it in 4 quarters since. The position peaked at $37.7M in Q1 2026. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Braidwell held 1,220,602 shares of CareDx worth $34.8M as of Q2 2026.
  • Braidwell sold 952,544 CareDx shares in Q2 2026, an estimated $20.7M.
  • CareDx made up 1.29% of Braidwell's portfolio in Q2 2026, its #28 holding.
  • Braidwell first reported a position in CareDx in Q3 2025 and has held it in 4 quarters since.
  • Braidwell's CareDx position peaked at $37.7M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.